Pixelligent Technologies LLC (Baltimore, Maryland) has secured $38 million in non-dilutive growth capital backed by its intellectual property portfolio. The capital was provided by a funding vehicle managed by MVolution Partners LLC and facilitated by insurance and valuation services provided by Aon. This additional growth capital brings the company’s total funding in this round to over $45 million, including equity capital from its strategic and financial shareholders.

Tiny particulates or noxious gases: From the day they are born, all people are exposed to a range of environmental forces. These forces constitute the exposome and affect the health and wellbeing of people around the world. A European research project has been set up to explore how the exposome affects the course of lung diseases. The microelectronics specialists at Fraunhofer IZM are on board and have developed a unique sensor bracelet that can pick up even tiniest concentrations of more than 40 individual harmful substances. The collected clinical data will show how these affect the lives of patients and may feed into more targeted and customised treatments.